CALLOS ANDREW (Chief Commercial Officer) sold 16.2% of their position (11.33K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $875.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0001061983-26-000047
Officer· Chief Commercial Officer
Since Mar 2021
-11.33K
Net shares
Net seller
$875.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
11.33K acquired · 22.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.33K
Price / share
$39.13
Trade value
$443.46K
% of position
19.4%
5/5/2026
58.55K→69.89K
Common Stock
Direct
Shares
−11.33K
Price / share
$77.25
Trade value
$875.47K
% of position
16.2%
5/5/2026
69.89K→58.55K
Total
Net shares
+0.00
Net value
-$432.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | M · Option Exercise | +11.33K | $39.13 | $443.46K | 19.4% | 58.55K | 69.89K |
| Common Stock Direct | 5/5/2026 | S · Sale | −11.33K | $77.25 | $875.47K | 16.2% | 69.89K | 58.55K |
| Total | +0.00 | -$432.01K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
11.33K shares
Shares
−11.33K
Strike price
39.13
Held after
13.07K
Exercisable
—
5/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) Direct | Common Stock11.33K shares | 5/5/2026 | M · Option Exercise | −11.33K | 39.13 | — | 13.07K |